Source study found

Story checked

New score predicts thrombosis risk in hospitalized pancreatitis patients (opens in a new tab)

news-medical.net · 2026-10-28

Short answerEvidenceSource

Short answer

Mostly supported

Mostly supported.

The claims we could check match the study, but some claims were not covered by the evidence reviewed.

5 supported
1 not covered

Checked against the study summary. The full text wasn't available, so some details couldn't be settled either way.

Share this check

Follow the evidence trail

The story

New score predicts thrombosis risk in hospitalized pancreatitis patients

news-medical.net · 2026-10-28

The story’s checkable claims.

Read the original story

NewsLink checks it

Mostly supported

Every claim we could check holds up. Five of six claims match the study. This overall rating is based only on the claims we could check. One claim the study doesn't address.

5 supported
1 not covered

Open claim evidence

The source study

A clinical risk score for early thrombosis detection in acute and chronic pancreatitis: insights from a large cohort study

eGastroenterology · 2026

Open source record Open in Tessa

Then inspect each claim

Evidence layer

Claim by claim

Each claim gets a verdict. Expand it to see the evidence directly below.

Reading mode

Scan verdicts. Open evidence only when needed.

Browse by verdict

6 claims in this story

Showing all 6 claimsChoose a verdict to focus the list.

Claim 1 of 6Not coveredThe primary outcome was any diagnosed deep vein thrombosis, pulmonary embolism, portal vein thrombosis, or other splanchnic vein thrombosis during hospitalization.View evidenceHide evidence

Why this verdict

The profile supports that the outcome was VTE during hospitalization and that DVT and PE were reported event types. However, at abstract-profile depth it does not verify the exact primary-outcome definition as including portal vein thrombosis or other splanchnic vein thrombosis.

Study evidence

Overall incidence of VTE in the pancreatitis cohort was 17.6% (114/647).114/647 (17.6%)

“We analysed VTE events in a large prospective cohort of patients with acute and chronic pancreatitis”

Claim 2 of 6SupportedProfessor Julia Mayerle and colleagues from LMU University Hospital Munich developed an admission-based score intended to identify pancreatitis patients more likely to be diagnosed with thrombosis during hospitalization.View evidenceHide evidence

Why this verdict

The abstract-profile evidence supports that the authors derived a six-item admission-time clinical risk score to identify pancreatitis patients at higher risk of in-hospital VTE/thrombosis. The supplied profile supports the LMU Klinikum Munich setting, though it does not independently verify the named professor/author detail at this depth.

Study evidence

A six-item admission-only integer score (0–8 points) derived from dichotomized admission predictors demonstrated modest discrimination for VTE (AUC 0.71) and stratified patients into low- (7.6%), intermediate- (22.0%) and high-risk (38.5%) groups.AUC 0.71; risk-group event rates: 7.6% / 22.0% / 38.5%

“The primary objective was to identify admission-time factors associated with VTE and develop a clinically actionable risk score.”

Claim 3 of 6SupportedAmong 647 adults, 114 patients (17.6%) had at least one thromboembolic event diagnosed during hospitalization.View evidenceHide evidence

As stated114 of 647 (17.6%)

Why this verdict

The profile states that among 647 pancreatitis patients, 114 developed VTE, corresponding to 17.6%.

Study evidence

Overall incidence of VTE in the pancreatitis cohort was 17.6% (114/647).114/647 (17.6%)

“We analysed VTE events in a large prospective cohort of patients with acute and chronic pancreatitis”

Study evidence

“The primary objective was to identify admission-time factors associated with VTE and develop a clinically actionable risk score.”

Claim 4 of 6SupportedA six-parameter score separated patients into low-, intermediate-, and high-risk groups with observed event rates of 7.6%, 22.0%, and 38.5%.View evidenceHide evidence

As stated7.6%, 22.0%, and 38.5%

Why this verdict

The profile reports a six-item admission-only score with observed VTE rates of 7.6%, 22.0%, and 38.5% in low-, intermediate-, and high-risk groups.

Study evidence

“The primary objective was to identify admission-time factors associated with VTE and develop a clinically actionable risk score.”

Claim 5 of 6SupportedThe model showed moderate discrimination but was assessed only in the cohort used to develop it, so prospective external validation is required.View evidenceHide evidence

Why this verdict

The profile reports AUC 0.71, which is consistent with modest/moderate discrimination, and states that performance was reported from the same single-centre cohort with no external validation reported in the abstract. The need for external validation is therefore appropriately framed as a limitation.

Study evidence

“The primary objective was to identify admission-time factors associated with VTE and develop a clinically actionable risk score.”

Claim 6 of 6SupportedThe study examined whether information available at admission could identify patients at higher risk of having thrombosis detected during the same hospital stay.View evidenceHide evidence

Why this verdict

The profile states that the primary objective was to identify admission-time factors associated with VTE and develop an admission-time score for VTE in pancreatitis, with events assessed during hospitalization.

Study evidence

“The primary objective was to identify admission-time factors associated with VTE and develop a clinically actionable risk score.”

Then look for missing context

Context layer

What the story left out

Important study details the story did not include.

Modeling limitation: continuous predictors were dichotomized using ROC-derived cut-points, which can reduce information and may affect score robustness.
This limitation appears in the paper profile but is not mentioned in the story caveats.
From retrospective analysis of a prospectively recruited cohort

8 things the story did carry across

Study design and setting: single-centre retrospective analysis of a prospectively recruited pancreatitis cohort at LMU Klinikum Munich.
Cohort and incidence: 647 patients with acute, acute-on-chronic, or chronic pancreatitis; 114/647 (17.6%) developed VTE.
Clinical associations: VTE was associated with longer hospitalization, greater disease severity/resource needs, and higher mortality.
Prediction-score finding: a six-item admission-only score had AUC 0.71 and stratified observed VTE rates into low-, intermediate-, and high-risk groups of 7.6%, 22.0%, and 38.5%.
Appropriate interpretation: the score may support earlier recognition or targeted diagnostic evaluation, but it is not established as a diagnostic test or treatment/anticoagulation decision rule.
Causal limitation: associations between VTE and worse outcomes are observational and may be confounded by pancreatitis severity or other factors.
Ascertainment limitation: the abstract profile does not detail VTE screening, diagnostic protocols, or timing, so event ascertainment may be biased or incomplete.
Validation limitation: score performance was reported from the development cohort, with no external validation, calibration metrics, or clinical-impact assessment reported in the abstract.

Then read the study layer

Study layer

Study at a glance

Scan the study first. Expand only the parts you want to inspect.

Pieces of work

Evidence read

study summary

Lead result

secondary data

1Lead resultsecondary dataDerive an admission-time clinical risk score predicting VTE in pancreatitis and assess its discrimination and risk stratification performance.retrospective analysis of a prospectively recruited cohortExpand

In plain English

Authors derived a six-item, admission-only (0–8 points) clinical risk score for venous thromboembolism (VTE) in patients admitted with acute or chronic pancreatitis using admission-time predictors dichotomized by ROC cut-points and a multivariable logistic regression model; the score discriminated modestly (AUC 0.71) and stratified patients into low- (7.6%), intermediate- (22.0%) and high-risk (38.5%) groups in a single-centre cohort (647 patients, 114 VTE events).

Key findings

A six-item admission-only integer score (0–8 points) derived from dichotomized admission predictors demonstrated modest discrimination for VTE (AUC 0.71) and stratified patients into low- (7.6%), intermediate- (22.0%) and high-risk (38.5%) groups.AUC 0.71; risk-group event rates: 7.6% / 22.0% / 38.5%
In the analysed cohort of 647 patients with pancreatitis, 114 (17.6%) experienced VTE; incidence was similar between acute (16.2%) and chronic pancreatitis (19.5%).114/647 (17.6%); acute 59/364 (16.2%), chronic 55/282 (19.5%)

“The primary objective was to identify admission-time factors associated with VTE and develop a clinically actionable risk score.”

What this piece can’t prove

Study is a retrospective analysis of a single-centre, prospectively recruited cohort—generalizability to other settings/populations is uncertain (abstract does not report external validation).
Continuous predictors were dichotomized using ROC-derived cut-points, which can reduce information and may affect model robustness.
Abstract does not report model calibration metrics, internal validation (e.g., bootstrapping or cross-validation) details, or the precise predictors and point weights included in the final score.

1 further detail could not be confirmed from the summary.

2secondary dataEstimate incidence and clinical phenotype of venous thromboembolism (including extrasplanchnic events) in a pancreatitis cohort and quantify its association with adverse outcomes (severity, length of stay, mortality).Retrospective analysis of a prospectively recruited clinical cohortExpand

In plain English

Single-centre retrospective analysis of a prospectively recruited cohort of 647 patients with acute, acute-on-chronic or chronic pancreatitis (Jan 2018–Jun 2023) reporting VTE incidence, event types, clinical correlates and associations with outcomes, and deriving a six-item admission-time clinical risk score (0–8 points) for VTE. Overall VTE incidence was 17.6% (114/647); DVT and PE were the most frequent event types. VTE was associated with longer hospitalisation, higher severity, greater need for advanced analgesia and higher mortality. A six-item score had AUC 0.71 and stratified patients into low-, intermediate- and high-risk groups (7.6%, 22.0%, 38.5% observed VTE rates).

Key findings

Overall incidence of VTE in the pancreatitis cohort was 17.6% (114/647).114/647 (17.6%)
Event types: deep vein thrombosis and pulmonary embolism were the most frequent VTE manifestations.DVT 5.9%; PE 4.2%

“We analysed VTE events in a large prospective cohort of patients with acute and chronic pancreatitis”

What this piece can’t prove

Single-centre study from a referral centre, which may limit generalisability.
Retrospective analysis of prospectively recruited cohort; abstract does not detail VTE screening/diagnostic protocols or timing, raising potential ascertainment bias.

2 further details could not be confirmed from the summary.

Finally, the search trail

Method layer